Aktie A2PQND HERAMED LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen HeraMED Limited

Aktien

A2PQND

AU0000028367

HMD

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 06:50:07 02.04.2024 		% 5 Tage % 1. Jan.
0,0175 AUD -12,50 % Intraday Chart für HeraMED Limited 0,00 % -27,08 %
13.03. HeraMED geht Partnerschaft mit FemBridge für Mutterschaftsgesundheitsdienst ein; Aktien springen um 15% MT
11.03. Heramed Limited kündigt Veränderungen im Vorstand an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
HeraMED Partners With FemBridge for Maternity Health Service; Shares Jump 15%
Heramed Limited Announces Board Changes
HeraMED Limited Reports Earnings Results for the Full Year Ended December 31, 2023
HeraMED Enters Strategic Collaboration with PHI Research
HeraMED Limited Announces Emily Slade to Resign as Non-Executive Director
HeraMED Enters Strategic Collaboration with GPEx
HeraMED Signs Deal with US-based Wingwomen for Cardio Initiative in Pregnant Women
HeraMED Concludes First Tranche of AU$1.25 Million Share Placement
HeraMED Signs Partnership Agreement with Telstra Health; Shares Climb 4%
HeraMED Launches Clinical Trial for Maternity Care Platform; Shares Surge 36%
HeraMED CEO Steps Down; CFO Transitions to EVP Role; Shares Surge 33%
HeraMED Limited Limited Announces Resignation of David Groberman as Chief Executive Officer with Immediate Effect
HeraMED Limited Announces Resignation of David Groberman as Managing Director
HeraMED Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Jianmin Pharmaceutical Group Co.,Ltd. completed the acquisition of 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd.
HeraMED Completes AU$2.58 Million Placement
HeraMED Transitions Chair to Executive Role
HeraMED's US Partner Signs Three-Year Commercial Deal with Caduceus Medical Group
HeraMED Signs Enterprise Agreement with Fond for HeraCARE Platform; Shares Decline 4%
Australian Shares Inch Down as Market Weighs Cooling, But Still High, US Inflation
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PQND Aktie
  4. Nachrichten HeraMED Limited
  5. Andere Sprachen